Recent Update

Leo Dryfruits received IRCTC empanelment under Category A in 'Millet Based Products' for its Vandu brand. The empanelment permits supply of millet mix and chikki to Indian Railways catering, including premium trains, subject to procurement process and bidding; no minimum business guaranteed.

Chief Financial Officer and Whole Time Director Tapan Gupta resigned effective July 29, 2026, citing pre-occupation, with no other material reasons disclosed.

CFO Surya Kant Sethia resigned (effective 14 Aug 2026) after 11 years; Board appointed Krishnamurthy Suryanarayan as CFO & Head-Strategy effective 15 Aug 2026. Suryanarayan brings 25+ years experience including CFO roles at Astec Lifesciences and Godrej Africa.

Board approved resignation of CFO Mr. Surya Kant Sethia (relieved 14 Aug 2026) and appointment of Mr. Krishnamurthy Suryanarayan as CFO effective 15 Aug 2026. Mr. Suryanarayan brings over 25 years of experience, previously CFO at ASTEC Lifesciences.

Rectification of SAST pledge disclosure: share count updated to 1,67,59,750 (5.11%) post stock split; no change in pledgor or percentage. Entity: Catalyst Trusteeship (not promoter).

Provigil Surveillance secured a Rs. 12.76 Cr purchase order from GAIL for integrated e-surveillance, marking Magellanic Cloud's entry into the Oil & Gas sector.

Sunita Tools signed a non-binding MoU with a Polish defence company for joint development of ISR drones, loitering ammunition, and smart flying ammunition — its first move into drone technology. Plans include a majority-owned JV and marketing rights across India, GCC, and subcontinent. No immediate financial impact.

BRGIL secured a ₹377.5 crore, 2-year toll collection & O&M contract from UPEIDA on Bundelkhand Expressway, with 10% annual escalation.

Received favorable ITAT order deleting ~₹1,305 Cr in tax demands across five years, based on APA and earlier rulings. No adverse financial impact, though tax department may appeal corporate tax portion.

Jindal Drilling received ONGC award for rig Jindal Pioneer at EDR ~$47,894/day for 3 years, starting Q3 FY27. Secures revenue for previously idle owned rig, reduces FY27 contract expiry risk.

L&T Energy CarbonLite Solutions secured LNTP for a mega ₹10,000-15,000Cr EPC order from NTPC for 2x800 MW ultra-supercritical thermal plant, subject to environmental clearance.

Provigil Surveillance secured a Rs 12.76 Cr order from GAIL for AI-enabled e-surveillance in NCR, marking entry into the oil & gas sector and expanding public sector footprint.

Yash Patel group acquired 1,438,000 shares of Purple Wave Infocom in open market, raising stake to 18.22%.

Amended purchase order from existing customer upsizes total to $324.62M (₹3,100Cr), an incremental $85.86M (₹820Cr). Execution timeline to be decided. Significant revenue boost.

MPID Court allowed one application, cancelling attachment of assets to implement the NSEL Scheme of Arrangement. More releases expected soon, advancing the ₹1,950 Cr OTS toward final execution.

Varun & Jyoti Kabra acquire 8.85% from Kolsite via inter-se transfer, promoter unchanged.

HFCL secured a ~₹441.53Cr export order for optical fiber cables from an international customer, to be executed by January 2027, reinforcing export momentum and adding to its record order book.

Bandhan Small Cap Fund allots 10.80L shares (5.08%) in L. T. Elevator via preferential allotment; non-promoter.

Pine View Portfolio Consultants (non-promoter) sold 540k shares (4.29% VR) of Adishakti Loha in open market on 27-28 Jul 2026, reducing stake from 8.36% to 4.07%.

Order book ₹5,143Cr, record Q1 inflow ₹2,895Cr; NWC 59 days; SLB data centre order ₹45Cr; PFBR criticality; greenfield Q3FY27

RPG Life Sciences to transfer API business to subsidiary RPG Active Pharma; InvAscent to invest up to INR 243 cr, and RPG Active Pharma to acquire Actis Generics, marking its first acquisition.

Bulk drug intermediates supplier for complex API ingredients

API subsidiary RPG Active Pharma to get Rs. 243.33 Cr PE infusion for 40% stake (commitment up to Rs. 700 Cr) and acquire Actis Generics for Rs. 80 Cr — first M&A after years; API slump sale to WOS for Rs. 33.55 Cr agreed.

Board approved slump sale of API business to WOS RPG Active Pharma for Rs 33.55 Cr. RPGAP to receive Rs 243.33 Cr from PE investors for ~40% stake (commitment upto Rs 700 Cr for growth) and acquire Actis Generics for Rs 80 Cr.

Board meeting on Aug 4 to approve Q1 FY27 results and a proposal to raise funds via equity, convertible bonds, or other securities through private placement, preferential issue, or QIP. This could dilute shareholders and signal cash strain.

AERA has issued ad-hoc aeronautical charges for Bhogapuram International Airport, effective from commercial operations date until the first control period. This de-risks the Q2FY27 commissioning timeline.

Revenue $405.4M (+4.4% QoQ), EBIT 13.6%. Reduced FY26 growth guidance to 6-7%, margin 13-14%. AI partner wins, consolidation deal in Top15 client.

FY27 guide revised to single-digit revenue degrowth, mid-20s EBITDA margin. Q1 rev -16% YoY. MoU with THSTI for clinical development.

Real estate development, buying, selling, leasing, developing land and buildings.

Board approved preferential issue of up to 17.32 lakh equity shares at Rs 900 per share for consideration other than cash (share swap) to promoter group members Yash Gopal Gupta and Sangeeta Gopalchand Gupta. EGM scheduled for August 25, 2026 to approve the issue.

Expleo Solutions' board recommended a final dividend of ₹110 per share for FY26, its first for the fiscal year, signaling return of cash to shareholders.

Acquirer and PAC signed SPA to buy 65.42% of ECS Biztech from promoters at Rs.2.26/share, triggering a mandatory open offer for 26% at Rs.10.50/share. The offer is not conditional on minimum acceptance.

Board-approved 8,500 TPA greenfield foundry (~₹120 Cr). FY27 >20% revenue growth, margins maintain. GET, defence ramp, new hybrid plant by Dec’26.

Board approved rights issue up to Rs 60 crore, enhanced inter-corporate loan/investment limits to Rs 100 crore, and proposed postal ballot for addition to object clause and increase in authorised share capital.

Lone Furrow Inv (Promoter) created addl pledge 29L shrs to restore security cover. No acq.

Promoter Lone Furrow created additional pledge of 29L shares; encumbrance now 68.62%.

Astral Limited withdrew the proposed demerger of its chemicals business after an independent review advised against it at the current scale. The board will reconsider once the chemicals business achieves greater size and financial strength.

Board decided to withdraw the Composite Scheme of Arrangement proposed in June 2026 for demerger of the Chemical business, citing insufficient scale. The demerger may be reconsidered once the business achieves greater financial strength.

Panyam Cements' CFO, P V N L Anil Kumar, has resigned effective 25 August 2026, citing personal reasons and to pursue external opportunities.

Steelcast reported Q1FY27 revenue of ₹124.8 Cr (+17% YoY) with PAT ₹23.7 Cr. EBITDA margin stable at 28%. Board approved a greenfield foundry of 8,500 tons capacity at ₹120 Cr investment, funded internally. Declared interim dividend of ₹0.45 per share.

Ameenji Rubber secured a Rs 47.46 crore LOA from Eastern Railway to supply Composite Grooved Rubber Pads over 18 months.

Board approved redemption of 95% of existing NCDs worth Rs 23.75 Cr and issuance of new secured NCDs aggregating Rs 30 Cr on private placement. Appointed Catalyst Trusteeship as trustee and Credora Partners as merchant banker for the issuance.

Capex Expansion, Margins Hold PAT at Rs 23.7 Cr in Q1 FY27, +19.3% YoY. Revenue at Rs 125 Cr in Q1 FY27, +17.0% YoY. EBITDA at Rs 35.2 Cr, +17.4% YoY. EBITDA margin at 28.2% vs 28.1%; cost of materials consumed grew 46% vs revenue growth of 17%. Board approved greenfield foundry of 8,500 tons capacity with investment of Rs 120 Cr, to be completed b

India's 1st commercial DME plant (100K TPA) commissioned; FY27 vol growth guided 10-15%, EBITDA margin target 22-23%; NMM, ACN on track.

India Pesticides Limited received registration approval for a fungicide formulation in Morocco, marking its entry into the Moroccan agrochemical market.

Revenue Dip, Profit Soars PAT at Rs 15.7 Cr in Q1 FY27, +51.7% YoY. Revenue at Rs 180 Cr in Q1 FY27, -21.1% YoY, reflecting higher software mix (agent model) as gross sales billed grew 5.7% to Rs 641 Cr. EBITDA at Rs 24.0 Cr, +39.2% YoY. EBITDA margin at 13.4% vs 7.6%; no one-off disclosed, expansion appears operational. CEO Shrikant Shitole resign

Sanjeev Goel (promoter) pre 34.98L (19.05%), post 47.56L (25.90%), off-mkt buy Bus Excellence Fund II.

Delhi High Court dismissed GCD Prime's petition to stay DCM's termination of the Hisar land development JDA. The court found no prima facie case for the developer, reinforcing DCM's termination. Arbitration proceedings are ongoing.